Aztreonam plus cefazolin: a double beta-lactam combination as empirical therapy in febrile cancer patients with or without granulocytopenia.
Menichetti
F
F
Infectious Diseases Institute, University of Perugia, Italy.
Bucaneve
G
G
Patoia
L
L
Guerciolini
R
R
Minotti
V
V
Pauluzzi
S
S
Del Favero
A
A
D000380:Agranulocytosis / Q000150:complications*; D001398:Aztreonam / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D002437:Cefazolin / Q000627:therapeutic use*; D002443:Ceftriaxone / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D005334:Fever / Q000188:drug therapy* / Q000209:etiology; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000302:isolation & purification; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications*
D002443:Ceftriaxone; D001398:Aztreonam; D002437:Cefazolin